Abilify Asimtufii, the bipolar I disorder treatment from Otsuka and Lundbeck, has entered the world of CGI animation as part ...

The most common side effects of ABILIFY ASIMTUFII or ABILIFY MAINTENA include: weight gain, restlessness or feeling like you need to move (akathisia), injection site pain, or sleepiness (sedation). It ...

Aripiprazole injection is used for the short-term treatment of agitation that occurs with certain mental/mood disorders (such as schizophrenia, bipolar disorder). Risperidone is used to treat ...

Aripiprazole 10mg, 15mg; vanilla flavor; contains phenylalanine. The mechanism of action of aripiprazole in the treatment of schizophrenia, bipolar I disorder, or adjunctive treatment of major ...

Proteus Digital Health developed the Abilify MyCite system with Otsaka America Pharmaceutical. Proteus later went bankrupt, though also developed smart pill solutions to treat other diseases like ...

Aripiprazole 1mg/mL; orange cream flavor; contains parabens. The mechanism of action of aripiprazole in the treatment of schizophrenia, bipolar I disorder, or adjunctive treatment of major ...

A new injectable, temporary pacemaker could help correct a heart arrhythmia in an emergency. This nanoparticle gel can regulate the heart’s electrical signals for up to five days before ...

Antipsychotic injectables, such as Abilify and Invega, tend to be most prevalent in street medicine practices. But street ...

Doctors use several injectable drugs for migraine. People may take some of these regularly to help prevent migraine attacks or reduce their severity. A person can take other treatments as they ...

If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

We tested the hypothesis that the combination of aripiprazole and clozapine would lead to an improvement in this patient group. Methods: Eleven patients with treatment-resistant schizophrenia ...

Pharmac – Te Pātaka Whaioranga is widening access to seven medicines, benefitting an estimated 5,700 people within the first year of funding. The decision includes treatments for schizophrenia, low ...